Search details
1.
HIV-1 expression within resting CD4+ T cells after multiple doses of vorinostat.
J Infect Dis
; 210(5): 728-35, 2014 Sep 01.
Article
in English
| MEDLINE | ID: mdl-24620025
2.
Mucosal tissue pharmacokinetics of the integrase inhibitor raltegravir in a humanized mouse model: Implications for HIV pre-exposure prophylaxis.
Virology
; 489: 173-8, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26771889
3.
Oseltamivir Population Pharmacokinetics in the Ferret: Model Application for Pharmacokinetic/Pharmacodynamic Study Design.
PLoS One
; 10(10): e0138069, 2015.
Article
in English
| MEDLINE | ID: mdl-26460484
4.
Genital Tenofovir Concentrations Correlate With Protection Against HIV Infection in the CAPRISA 004 Trial: Importance of Adherence for Microbicide Effectiveness.
J Acquir Immune Defic Syndr
; 69(3): 264-9, 2015 Jul 01.
Article
in English
| MEDLINE | ID: mdl-26181703
5.
A single-dose mass balance and metabolite-profiling study of vemurafenib in patients with metastatic melanoma.
Pharmacol Res Perspect
; 3(2): e00113, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25729580
6.
HIV pre-exposure prophylaxis: mucosal tissue drug distribution of RT inhibitor Tenofovir and entry inhibitor Maraviroc in a humanized mouse model.
Virology
; 464-465: 253-263, 2014 Sep.
Article
in English
| MEDLINE | ID: mdl-25105490
7.
A multi-compartment single and multiple dose pharmacokinetic comparison of rectally applied tenofovir 1% gel and oral tenofovir disoproxil fumarate.
PLoS One
; 9(10): e106196, 2014.
Article
in English
| MEDLINE | ID: mdl-25350119
Results
1 -
7
de 7
1
Next >
>>